LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

Search

Phreesia Inc

Fermé

SecteurSoins de santé

22.74 0.49

Résumé

Variation du prix de l'action

24h

Actuel

Min

22.41

Max

22.98

Chiffres clés

By Trading Economics

Revenu

4.6M

654K

Ventes

1.3M

117M

Marge bénéficiaire

0.558

Employés

2,082

EBITDA

2.7M

6.8M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+55.9% upside

Dividendes

By Dow Jones

Prochains Résultats

8 déc. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-522M

1.4B

Ouverture précédente

22.25

Clôture précédente

22.74

Sentiment de l'Actualité

By Acuity

50%

50%

170 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Neutral Evidence

Phreesia Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

11 nov. 2025, 23:59 UTC

Résultats

Singtel's 1st Half Net Profit Surges

11 nov. 2025, 22:23 UTC

Acquisitions, Fusions, Rachats

Mineral Resources Sells Stake in Lithium Mines to Posco For $765 Million

11 nov. 2025, 22:21 UTC

Résultats

Aristocrat Boosts Dividend as Annual Profit Rises 12%

11 nov. 2025, 23:52 UTC

Market Talk

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

11 nov. 2025, 23:44 UTC

Résultats

Singtel's 1H Net Profit Surges

11 nov. 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound Amid Caution over U.S. Econ Strength -- Market Talk

11 nov. 2025, 23:18 UTC

Résultats

Singtel: Expects FY Operating Company EBIT to Grow Between High Single Digits and Low Double Digits Vs. Earlier Guidance of High Single-Digit Growth >Z74.SG

11 nov. 2025, 23:15 UTC

Résultats

Singtel: Interim Dividend of 8.2 Singapore Cents per Share, up 17% >Z74.SG

11 nov. 2025, 23:14 UTC

Résultats

Singtel 1H Underlying Net Profit S$1.35B, Up 14% >Z74.SG

11 nov. 2025, 23:12 UTC

Résultats

Singtel 1H Net Exceptional Gain of S$2.05B >Z74.SG

11 nov. 2025, 23:11 UTC

Résultats

Singtel 1H Net S$3.40B Vs. Net S$1.23B >Z74.SG

11 nov. 2025, 23:10 UTC

Résultats

Singtel 1H Rev S$6.91B Vs. S$6.99B >Z74.SG

11 nov. 2025, 23:04 UTC

Market Talk

RBA Will Sharply Focus On Australian Jobs Report -- Market Talk

11 nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

11 nov. 2025, 21:50 UTC

Market Talk
Résultats

Health Care Roundup: Market Talk

11 nov. 2025, 21:46 UTC

Market Talk
Acquisitions, Fusions, Rachats

Private Equity Can Benefit From 'Deal-Friendly' Antitrust Policies -- Market Talk

11 nov. 2025, 21:41 UTC

Résultats

Aristocrat: Continues to Actively Pursue Strategic M&A Opportunities

11 nov. 2025, 21:40 UTC

Résultats

Aristocrat: Expects to Deliver Npata Growth Over FY 2026 on a Constant Currency Basis

11 nov. 2025, 21:39 UTC

Résultats

Aristocrat: Interactive Delivered Revenue Growth Mainly Due to Inclusion of NeoGames

11 nov. 2025, 21:39 UTC

Résultats

Aristocrat: Key Social Casino Franchises Continued to Outperform Market

11 nov. 2025, 21:39 UTC

Résultats

Aristocrat: Gaming Unit Continued to Deliver Market Share Gains

11 nov. 2025, 21:38 UTC

Résultats

Aristocrat: FY Normalized Npata Up 9% in Constant Currency

11 nov. 2025, 21:38 UTC

Résultats

Aristocrat: Final Dividend 49 Australian Cents/Share

11 nov. 2025, 21:37 UTC

Résultats

Aristocrat: FY Statutory Net Profit from Continuing Ops A$1.18 Bln, Up 2.9%

11 nov. 2025, 21:36 UTC

Résultats

Aristocrat: FY Normalized Operating Revenue A$6.3 Bln, Up 11%

11 nov. 2025, 21:35 UTC

Résultats

Aristocrat: FY Normalized Npata A$1.55 Bln, Up 12.2%

11 nov. 2025, 21:35 UTC

Résultats

Alcon 3Q Adj EPS 79c >ALC

11 nov. 2025, 21:35 UTC

Résultats

Alcon 3Q Rev $2.61B >ALC.EB

11 nov. 2025, 21:35 UTC

Résultats

Alcon Backs 2025 EPS $3.05-EPS $3.15 >ALC.EB

11 nov. 2025, 21:35 UTC

Résultats

Alcon 3Q EPS 48c >ALC.EB

Comparaison

Variation de prix

Phreesia Inc prévision

Objectif de Prix

By TipRanks

55.9% hausse

Prévisions sur 12 Mois

Moyen 34.33 USD  55.9%

Haut 38 USD

Bas 32 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

11 ratings

11

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

25.23 / 25.61Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

170 / 374Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
help-icon Live chat